Risedronate
Risedronate (Actonel) is a bisphosphonate medicine used to treat postmenopausal osteoporosis and Paget’s disease of bone. The catalogue contains one formulation.
Key points
- Risedronate belongs to a class of medicines called bisphosphonates, which slow bone loss and maintain bone density.
- The single formulation listed is a 35 mg tablet, the originator brand Actonel from Procter & Gamble Pharmaceuticals.
Common questions about Risedronate
Is Actonel a generic medicine?
No. Actonel is the brand name for risedronate. Both contain the same active ingredient at the same strength, so they work identically.
What conditions is risedronate listed for?
Risedronate is listed for postmenopausal osteoporosis and Paget’s disease of bone, both conditions that affect bone strength and density and are grouped under the Bone Health category.
